Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 9/2018

01-09-2018 | Review

Portal Vein Embolization Utilizing N-Butyl Cyanoacrylate for Contralateral Lobe Hypertrophy Prior to Liver Resection: A Systematic Review and Meta-Analysis

Authors: Ethan Wajswol, Tarek Jazmati, Sohail Contractor, Abhishek Kumar

Published in: CardioVascular and Interventional Radiology | Issue 9/2018

Login to get access

Abstract

Purpose

To evaluate the safety and effectiveness of n-butyl cyanoacrylate (NBCA) for portal vein embolization (PVE) when used to induce contralateral future liver remnant (FLR) hypertrophy in patients undergoing planned hepatic resection for hepatic malignancy.

Materials and Methods

The PubMed database (including articles indexed by MEDLINE) was searched for articles published from 1970 to 2018 describing patients treated with PVE utilizing NBCA to induce hypertrophy of the FLR prior to contralateral hepatic lobe resection. Demographic data, embolization technique, complications of embolization, resultant FLR hypertrophy, and surgical outcomes were obtained when available. A meta-analysis was performed to determine the cumulative relative hypertrophy rate of the FLR following PVE with NBCA.

Results

The literature search yielded 18 relevant articles. Six hundred and seven patients (383 men, 220 women; mean age 60.7 years) with procedures describing PVE utilizing NBCA were reviewed. The most common underlying hepatic malignancies were colorectal metastases (n = 348), followed by cholangiocarcinomas (n = 92), and hepatocellular carcinomas (n = 89). Technical success was reportedly achieved in 603/607 patients, for a success rate of 99.3%. Fixed effects meta-analysis of the relative hypertrophy rate of the FLR among studies resulted in an aggregate rate of 49.4 ± 1.3%. Of the patients who underwent attempted PVE, 461/607 (75.9%) eventually underwent surgical resection. Major complications following PVE occurred in 19 patients (3.13%), while minor complications following PVE occurred in 38 patients (6.26%).

Conclusions

PVE utilizing NBCA to induce hypertrophy of the FLR prior to contralateral lobe resection in the setting of hepatic malignancy is safe and effective.

Level of Evidence

Level IIa—Systematic review of cohort studies.
Literature
1.
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1271–80.CrossRefPubMed
2.
Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232(5):665–72.CrossRefPubMedPubMedCentral
3.
de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology (Baltimore, MD). 1996;24(6):1386–91.CrossRef
4.
Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57.CrossRefPubMed
5.
van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Interv Radiol. 2013;36(1):25–34.CrossRef
6.
Denys A, Bize P, Demartines N, Deschamps F, De Baere T. Quality improvement for portal vein embolization. Cardiovasc Interv Radiol. 2010;33(3):452–6.CrossRef
7.
Barbaro B, Caputo F, Tebala C, et al. Preoperative right portal vein embolisation: indications and results. Radiol Med (Torino). 2009;114(4):553–70.CrossRef
8.
Bellemann N, Stampfl U, Sommer CM, Kauczor HU, Schemmer P, Radeleff BA. Portal vein embolization using a histoacryl/lipiodol mixture before right liver resection. Dig Surg. 2012;29(3):236–42.CrossRefPubMed
9.
Bent CL, Low D, Matson MB, Renfrew I, Fotheringham T. Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. Cardiovasc Interv Radiol. 2009;32(3):471–7.CrossRef
10.
Broering DC, Hillert C, Krupski G, et al. Portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2002;6(6):905–13 ; discussion 913.CrossRef
11.
Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Archiv Surg (Chicago, Ill: 1960). 2008;143(10):978–82 ; discussion 982.CrossRef
12.
de Baere T, Teriitehau C, Deschamps F, et al. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol. 2010;17(8):2081–9.CrossRefPubMed
13.
Denys A, Lacombe C, Schneider F, et al. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol JVIR. 2005;16(12):1667–74.CrossRefPubMed
14.
Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery. 2008;143(4):476–82.CrossRefPubMed
15.
Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Interv Radiol. 2013;36(5):1306–12.CrossRef
16.
Jaberi A, Toor SS, Rajan DK, et al. Comparison of clinical outcomes following glue versus polyvinyl alcohol portal vein embolization for hypertrophy of the future liver remnant prior to right hepatectomy. J Vasc Interv Radiol JVIR. 2016;27(12):1897.e1891–1905.e1891.CrossRef
17.
Kaneko T, Nakao A, Takagi H. Clinical studies of new material for portal vein embolization: comparison of embolic effect with different agents. Hepatogastroenterology. 2002;49(44):472–7.PubMed
18.
Kim GC, Bae JH, Ryeom HK. Percutaneous preoperative portal vein embolization using a combination of gelatin sponge and histoacryl glue. Acta Radiol (Stockholm, Sweden: 1987). 2009;50(10):1119–25.
19.
Lindner P, Cahlin C, Friman S, et al. Extended right-sided liver resection for colorectal liver metastases–impact of percutaneous portal venous embolisation. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2006;32(3):292–6.
20.
Perarnau JM, Daradkeh S, Johann M, Deneuville M, Weinling P, Coniel C. Transjugular preoperative portal embolization (TJPE) a pilot study. Hepatogastroenterology. 2003;50(51):610–3.PubMed
21.
Peregrin JH, Janousek R, Kautznerova D, et al. A comparison of portal vein embolization with poly(2-hydroxyethylmethacrylate) and a histoacryl/lipiodol mixture in patients scheduled for extended right hepatectomy. Physiol Res. 2015;64(6):841–8.PubMed
22.
Sirichindakul B, Nonthasoot B, Taesombat W, et al. Role of portal vein embolization in hepatobiliary malignancy. Hepatogastroenterology. 2007;54(80):2297–300.PubMed
23.
Denys AL, Abehsera M, Sauvanet A, Sibert A, Belghiti J, Menu Y. Failure of right portal vein ligation to induce left lobe hypertrophy due to intrahepatic portoportal collaterals: successful treatment with portal vein embolization. AJR Am J Roentgenol. 1999;173(3):633–5.CrossRefPubMed
24.
Angle JF, Siddiqi NH, Wallace MJ, et al. Quality improvement guidelines for percutaneous transcatheter embolization: society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol JVIR. 2010;21(10):1479–86.CrossRefPubMed
25.
Makuuchi M, Takayasu K, Takuma T, et al. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J Jpn Pract Surg Soc. 1984;45(12):1558–64.
26.
Loffroy R, Favelier S, Chevallier O, et al. Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes. Quant Imaging Med Surg. 2015;5(5):730–9.PubMedPubMedCentral
27.
van den Esschert JW, van Lienden KP, Alles LK, et al. Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model. Ann Surg. 2012;255(2):311–8.CrossRefPubMed
28.
Tsoumakidou G, Theocharis S, Ptohis N, et al. Liver hypertrophy after percutaneous portal vein embolization: comparison of N-butyl-2-cyanocrylate versus sodium acrylate-vinyl alcohol copolymer particles in a swine model. Cardiovasc Interv Radiol. 2011;34(5):1042–9.CrossRef
29.
de Baere T, Denys A, Paradis V. Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol. 2009;19(6):1435–42.CrossRefPubMed
30.
Vinters HV, Galil KA, Lundie MJ, Kaufmann JC. The histotoxicity of cyanoacrylates. A selective review. Neuroradiology. 1985;27(4):279–91.CrossRefPubMed
31.
Kish KK, Rapp SM, Wilner HI, Wolfe D, Thomas LM, Barr J. Histopathologic effects of transarterial bucrylate occlusion of intracerebral arteries in mongrel dogs. AJNR Am J Neuroradiol. 1983;4(3):385–7.PubMed
32.
Levrier O, Mekkaoui C, Rolland PH, et al. Efficacy and low vascular toxicity of embolization with radical versus anionic polymerization of n-butyl-2-cyanoacrylate (NBCA). An experimental study in the swine. J Neuroradiol. 2003;30(2):95–102.PubMed
33.
Koga M, Ogasawara H. Induction of hepatocyte mitosis in intact adult rat by interleukin-1 alpha and interleukin-6. Life Sci. 1991;49(17):1263–70.CrossRefPubMed
34.
Feingold KR, Soued M, Grunfeld C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun. 1988;153(2):576–82.CrossRefPubMed
35.
de Baere T, Roche A, Vavasseur D, et al. Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology. 1993;188(1):73–7.CrossRefPubMed
36.
Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88(2):165–75.CrossRefPubMed
37.
Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology (Baltimore, MD). 1999;29(4):1099–105.CrossRef
38.
Di Stefano DR, de Baere T, Denys A, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology. 2005;234(2):625–30.CrossRefPubMed
Metadata
Title
Portal Vein Embolization Utilizing N-Butyl Cyanoacrylate for Contralateral Lobe Hypertrophy Prior to Liver Resection: A Systematic Review and Meta-Analysis
Authors
Ethan Wajswol
Tarek Jazmati
Sohail Contractor
Abhishek Kumar
Publication date
01-09-2018
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 9/2018
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-018-1964-6

Other articles of this Issue 9/2018

CardioVascular and Interventional Radiology 9/2018 Go to the issue

Clinical Investigation

Transcatheter Arterial Embolization for Bleeding Peptic Ulcers: A Multicenter Study

Clinical Investigation

Percutaneous Radiofrequency Ablation for the Treatment of Osteoid Osteoma in Children and Adults: A Comparative Analysis in 92 Patients

Technical Note

90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material

Case Report

Successful Balloon-Assisted Hepatic Tract Embolization Using the Pull-Through Technique to Remove a Malpositioned Chest Tube Penetrating the Liver and into the Right Ventricle

Letter to the Editor

Endolymphatic Optical Coherence Tomography Facilitates Evaluation of the Thoracic Duct Prior to Embolization

Clinical Investigation

Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization